ea0011s53 | Endocrinology in the foetus | ECE2006
Grueters A
Endocrine fetal therapies is currently performed in congenital adrenal hyperplasia due to 21-hydroxylase and 11 beta-hydroxylase deficiencies (CAH), hypothyroidism accompanied by large goiter and in thyrotoxicosis due to maternal autoantibodies. In CAH dexamethasone is administered to the mother 56 weeks p.c. to suppress the fetal hypothalamo-pituitary-adrenal axis. If the diagnosis is confirmed by chorionic villus or amniocentesis therapy is continued, while it is disco...